The paper proposes a method to predict optimal screening intervals for breast cancer patients, aiming to reduce both screening and delay costs. This approach is personalized, incorporating the patient's medical history alongside external data. Overall, the paper is well-written, and the proposed method demonstrates notable advancements compared to existing approaches.